Article - European Medical Journal

Continue

Articles

Urology
25 Jun 2015

Learning Curve of Robotic Radical Prostatectomy

Introduction: Prostate cancer (PrC) is the fifth most common malignancy worldwide and the second most common malignancy in men…
Urology
25 Jun 2015

Outcomes of Robotic Radical Prostatectomy in High-risk Prostate Cancer Patients: Experience in 60 Patients with Oncological and Functional Outcomes

Introduction: In this retrospective study, we report outcomes of robot-assisted laparoscopic radical prostatectomy (RARP) in high-risk prostate cancer…
Urology
25 Jun 2015

Percutaneous Nephrolithotomy and Complications: Our Experience with 3,003 Cases

We report the outcomes of 3,003 percutaneous nephrolithotomy (PCNL) procedures performed in our institution between March 1998 and December 2014…
Urology
25 Jun 2015

Outcomes of Six Patients Who were Treated with Selective Embolisation Due to Arteriovenous Fistula Following Percutaneous Nephrolithotomy

Objective: Arteriovenous fistula (AVF) is a rare yet serious complication of percutaneous nephrolithotomy (PCNL). The aim of this study was to…
Urology
25 Jun 2015

Effectiveness of Flexible Ureteroscopy and Laser Lithotripsy in the Management of Urinary Calculi in Patients with Congenital Abnormalities of the Kidney and Ureter

Introduction: We present our experience with retrograde intrarenal surgery (RIRS) in patients with calculi in congenital anomalies of the upper urinary…
Urology
25 Jun 2015

Percutaneous Nephrolithotomy for Paediatric Stone Disease

We evaluated the outcomes and complications occurring following percutaneous nephrolithotomy (PCNL) procedures performed in paediatric patients.
EMJ
Oncology
2 Mins
4 Jun 2015

The Last Frontier, Men’s Health

The 21st century is well upon us, and the scientific and health landscape is rapidly changing, yet there are still new horizons to conquer.
EMJ
Oncology
2 Jun 2015

Pembrolizumab Shows Promising Activity Against Head and Neck Cancer

A 132-patient study indicates that pembrolizumab immunotherapy is effective for patients with recurrent or metastatic head and neck cancer (HNC). The…